Trial Profile
A Study Investigating the Association between Overall Osteoporosis Medication Persistence and Fracture Risk in Female Patients Diagnosed with Osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2018
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary) ; Denosumab (Primary) ; Raloxifene (Primary) ; Teriparatide (Primary) ; Bisphosphonates
- Indications Osteoporosis
- Focus Therapeutic Use
- 18 Jan 2018 New trial record